Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Gynecology · Genitourinary Syndrome of Menopause

Can Low Estrogen Cause UTI Symptoms With Negative Cultures?

At a Glance

Low estrogen after menopause can cause Genitourinary Syndrome of Menopause, leading to burning, urinary urgency, and frequent urination that mimic a UTI. A negative culture does not prove the cause; clinicians should assess for infection and other conditions before considering local vaginal estrogen.

Yes—low estrogen resulting in Genitourinary Syndrome of Menopause (GSM) is a common cause, though a negative culture does not by itself diagnose GSM. As estrogen levels decline during and after menopause, you can develop urinary urgency, frequency, and burning that feel exactly like a urinary tract infection (UTI) [1][2]. This happens because the tissues of your urinary tract rely on estrogen to stay thick, elastic, and healthy. When estrogen falls, these tissues thin out and become easily irritated [3].

Why Low Estrogen Mimics a UTI

The lower urinary tract—specifically the urethra (the tube that carries urine out) and the base of the bladder (the trigone)—is rich in estrogen receptors [4][1]. These tissues need steady estrogen to function normally.

When menopause causes estrogen levels to decline, the urinary and vaginal tissues experience a cluster of changes known as Genitourinary Syndrome of Menopause (GSM) [5]. This lack of estrogen leads to:

  • Tissue Thinning (Atrophy): The lining of the urethra and estrogen-responsive vulvovaginal tissues lose collagen, elastin, and thickness [3]. The thinned tissue becomes fragile and sensitive, causing burning and pain (dysuria) [2].
  • Loss of Elasticity: As the tissues lose their stretch, the bladder can become irritated more easily, leading to a sudden, intense need to urinate (urgency) and needing to go more often (frequency) [3][6].
  • Microbiome Shifts: Estrogen normally feeds healthy Lactobacillus bacteria in the vagina, which keep the environment slightly acidic. Without estrogen, the vaginal pH rises (becomes less acidic), the microbial community shifts, and the area becomes more vulnerable to irritation and bacterial infections [7][8].

Because burning, urgency, and frequency overlap so closely with the symptoms of a bacterial infection, it is very common to mistake a GSM flare for a UTI [9][2].

Interpreting Negative Cultures and Other Causes

If you feel like you have a UTI, a clinician will likely request a urine culture to check for bacterial growth. In one large study of postmenopausal women with UTI-like symptoms, nearly 40% of completed urine cultures came back negative [9].

However, a negative culture does not automatically prove you have GSM. Cultures can sometimes be falsely negative if you started antibiotics before providing the sample, or if the bacterial count was low. Persistent or negative-culture symptoms also require considering other conditions, such as overactive bladder, pelvic-floor dysfunction, interstitial cystitis (bladder pain syndrome), sexually transmitted infections, or kidney stones [10][11].

When to Seek Urgent Care
Do not assume all urinary symptoms are just low estrogen. Seek prompt medical assessment if you experience fever, chills, back or flank pain, vomiting, visible blood in your urine, inability to urinate, or severe, worsening pain.

The Challenge of Repeated Antibiotics

Because symptoms are so similar, many women with GSM are repeatedly prescribed antibiotics while waiting for culture results—or even after a negative culture [9].

Taking antibiotics when they aren’t needed does not treat the root cause of estrogen-deprived tissue. Furthermore, unnecessary antibiotic use can disrupt your gut and vaginal microbiome, cause yeast infections, and increase your risk of developing antibiotic-resistant bacteria [12].

Important: Never stop a prescribed antibiotic on your own, even if a culture comes back negative. Always contact your clinician for guidance, as they interpret the culture alongside your history and urinalysis.

An Evidence-Based Option: Local Estrogen Therapy

If your clinician determines your recurrent symptoms are caused by GSM, low-dose local (vaginal) estrogen is an evidence-based option [13][8]. For mild dryness, non-hormonal vaginal moisturizers and lubricants can help, but for urinary symptoms, estrogen is often more targeted to the underlying tissue changes [14].

Local (vaginal) estrogen comes in low-dose creams, dissolving inserts, or flexible rings placed in the vagina. This therapy works by:

  • Improving the health, thickness, and elasticity of estrogen-responsive vulvovaginal and urethral tissues [3][15].
  • Restoring a healthy, acidic vaginal pH and encouraging protective Lactobacillus bacteria to return [16][12].
  • Reducing the burning, urgency, and frequency associated with GSM [13].
  • Decreasing the risk of recurrent, confirmed bacterial UTIs [17][18].

Safety and Timeline:
Local estrogen usually results in low systemic absorption [14][19]. However, it is not appropriate for everyone. You should discuss this option carefully with your clinician—and your oncology team, if applicable—if you have unexplained vaginal bleeding, or a history of breast or endometrial cancer [20][21].

Additionally, unlike an antibiotic that can clear a bacterial infection in a few days, local estrogen needs time to work. It typically takes weeks to months of consistent use, following the specific instructions for your prescribed product, to see significant relief from urinary symptoms [22][18].

Common questions in this guide

Can menopause-related low estrogen cause burning and urgency even if my urine culture is negative?
Yes. Declining estrogen can cause Genitourinary Syndrome of Menopause, which thins and irritates tissues around the vagina, urethra, and bladder and may lead to burning, urgency, and frequent urination. A negative culture can support considering this condition, but it does not diagnose it by itself.
Does a negative urine culture prove that I do not have a UTI?
No. A culture may be negative if antibiotics were taken before the sample was collected or if the bacterial level is low. Persistent symptoms may also come from overactive bladder, pelvic-floor dysfunction, bladder pain syndrome, a sexually transmitted infection, or kidney stones, so a clinician should interpret the result with your symptoms and urinalysis.
How can I tell Genitourinary Syndrome of Menopause apart from a bacterial UTI?
They can feel very similar, so symptoms alone cannot reliably distinguish them. Vaginal dryness, irritation, or pain during sex may point toward Genitourinary Syndrome of Menopause, while a clean-catch urine test and culture help assess for bacterial infection. A clinician may also check for other bladder, pelvic-floor, vaginal, or sexually transmitted causes.
Can vaginal estrogen help with UTI-like symptoms after menopause?
Low-dose local vaginal estrogen can improve the health of vulvovaginal and urethral tissues and may reduce burning, urgency, and frequent urination related to Genitourinary Syndrome of Menopause. It can also lower the risk of recurrent confirmed bacterial UTIs, but it usually takes weeks to months to provide substantial urinary relief. Discuss it with a clinician, especially if you have unexplained bleeding or a history of breast or endometrial cancer.
How long does local vaginal estrogen take to work for urinary symptoms?
Unlike an antibiotic, local vaginal estrogen does not usually relieve symptoms within a few days. Consistent use as prescribed may take weeks to months before urinary symptoms improve significantly. Follow the product instructions and contact your clinician if symptoms persist or worsen.
When should urinary symptoms be treated as urgent?
Seek prompt medical assessment for fever, chills, back or flank pain, vomiting, visible blood in the urine, inability to urinate, or severe or worsening pain. These symptoms should not be assumed to be caused only by low estrogen or Genitourinary Syndrome of Menopause.

Get notified when new evidence is published on postmenopausal atrophic vaginitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    Consensus statement - Urogenital atrophy.

    Briggs P

    Post reproductive health 2022; (28(1)):47-50 doi:10.1177/20533691211065808.

    PMID: 35103527
  2. 2

    Hormonal Approach for Postmenopausal Vulvovaginal Atrophy.

    Costa APF, Sarmento ACA, Vieira-Baptista P, et al.

    Frontiers in reproductive health 2021; (3()):783247 doi:10.3389/frph.2021.783247.

    PMID: 36303971
  3. 3

    Genitourinary syndrome of menopause treatment using lasers and temperature-controlled radiofrequency.

    Wańczyk-Baszak J, Woźniak S, Milejski B, Paszkowski T

    Przeglad menopauzalny = Menopause review 2018; (17(4)):180-184 doi:10.5114/pm.2018.81743.

    PMID: 30766466
  4. 4

    Treatment of the genitourinary syndrome of menopause.

    Palacios S, Mejía A, Neyro JL

    Climacteric : the journal of the International Menopause Society 2015; (18 Suppl 1()):23-9 doi:10.3109/13697137.2015.1079100.

    PMID: 26366797
  5. 5

    Vaginal Estrogen: Pearls for the Practitioner A Practical Review of Evidence, Guidelines, and Prescribing Strategies for Genitourinary Syndrome of Menopause.

    Perelmuter S, Srivastava M, Freedman KP, et al.

    Journal of women's health (2002) 2026; (35(10)):900-907 doi:10.1177/15409996261465193.

    PMID: 42381200
  6. 6

    Nocturia in Menopausal Women: The Link Between Two Common Problems of the Middle Age.

    Pauwaert K, Goessaert AS, Robinson D, et al.

    International urogynecology journal 2024; (35(5)):935-946 doi:10.1007/s00192-024-05743-1.

    PMID: 38436669
  7. 7

    Menopause, skin and common dermatosis. Part 3: genital disorders.

    Musbahi E, Kamp E, Ashraf M, DeGiovanni C

    Clinical and experimental dermatology 2022; (47(12)):2123-2129 doi:10.1111/ced.15400.

    PMID: 36103137
  8. 8

    Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause.

    Buck ES, Lukas VA, Rubin RS

    Urology 2021; (151()):31-36 doi:10.1016/j.urology.2020.05.058.

    PMID: 32533967
  9. 9

    Underdiagnosed and overmedicated: Investigating the management of urinary tract infection and vaginal estrogen use in a large cohort of postmenopausal women.

    Nahum R, Machtinger R, Oberman B, et al.

    Maturitas 2025; (205()):108806 doi:10.1016/j.maturitas.2025.108806.

    PMID: 41406900
  10. 10

    Deconstructing the genitourinary syndrome of menopause.

    Vieira-Baptista P, Marchitelli C, Haefner HK, et al.

    International urogynecology journal 2017; (28(5)):675-679 doi:10.1007/s00192-017-3295-6.

    PMID: 28293790
  11. 11

    Diagnosis, causes, and treatment of dyspareunia in postmenopausal women.

    Streicher LF

    Menopause (New York, N.Y.) 2023; (30(6)):635-649 doi:10.1097/GME.0000000000002179.

    PMID: 37040586
  12. 12

    Preventing urinary tract infections after menopause without antibiotics.

    Caretto M, Giannini A, Russo E, Simoncini T

    Maturitas 2017; (99()):43-46 doi:10.1016/j.maturitas.2017.02.004.

    PMID: 28364867
  13. 13

    Menopause hormone therapy and urinary symptoms: a systematic review.

    Christmas MM, Iyer S, Daisy C, et al.

    Menopause (New York, N.Y.) 2023; (30(6)):672-685 doi:10.1097/GME.0000000000002187.

    PMID: 37192832
  14. 14

    The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.

    Menopause (New York, N.Y.) 2020; (27(9)):976-992 doi:10.1097/GME.0000000000001609.

    PMID: 32852449
  15. 15

    The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause.

    Kaufman MR, Ackerman AL, Amin KA, et al.

    The Journal of urology 2025; (214(3)):242-250 doi:10.1097/JU.0000000000004589.

    PMID: 40298120
  16. 16

    Vulvovaginal estrogen therapy for urinary symptoms in postmenopausal women: a review and meta-analysis.

    Porcari I, Uccella S, Casprini C, et al.

    Climacteric : the journal of the International Menopause Society 2026; (29(1)):13-22 doi:10.1080/13697137.2025.2517138.

    PMID: 40569036
  17. 17

    Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.

    Chen YY, Su TH, Lau HH

    International urogynecology journal 2021; (32(1)):17-25 doi:10.1007/s00192-020-04397-z.

    PMID: 32564121
  18. 18

    Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial.

    Muiños Fernández N, Martínez Salamanca JI, Pardo González de Quevedo JI, et al.

    Maturitas 2024; (190()):108128 doi:10.1016/j.maturitas.2024.108128.

    PMID: 39388913
  19. 19

    Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review.

    Danan ER, Sowerby C, Ullman KE, et al.

    Annals of internal medicine 2024; (177(10)):1400-1414 doi:10.7326/ANNALS-24-00610.

    PMID: 39250810
  20. 20

    Menopausal hormone therapy and breast cancer: risk and management.

    Sanserino K

    Current opinion in obstetrics & gynecology 2026; (38(2)):117-122 doi:10.1097/GCO.0000000000001094.

    PMID: 41696755
  21. 21

    Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy.

    Sussman TA, Kruse ML, Thacker HL, Abraham J

    Journal of oncology practice 2019; (15(7)):363-370 doi:10.1200/JOP.18.00710.

    PMID: 31291563
  22. 22

    Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.

    Caruso S, Cianci S, Amore FF, et al.

    Menopause (New York, N.Y.) 2016; (23(1)):47-54 doi:10.1097/GME.0000000000000485.

    PMID: 26079974

This page explains how low estrogen and Genitourinary Syndrome of Menopause may cause UTI-like symptoms for informational purposes only and does not constitute medical advice. Consult a clinician for persistent symptoms, negative cultures, urgent warning signs, or decisions about antibiotics and vaginal estrogen.